Speaker illustration

Doctor Stephen Brennan

Mater Misericordiae University Hospital, Dublin (Ireland)

Member of:

European Society of Cardiology

Interleukin-6 signalling, lipoprotein (a) lowering and cardiovascular disease: a mendelian randomisation study

Event: ESC Congress 2024

Topic: Drug therapy

Session: Dyslipidaemia: novel diagnostics and therapy options

Thumbnail

Impact of antihypertensive medication regimens on blood pressure control in individuals with established coronary heart disease

Event: ESC Congress 2022

Topic: Secondary Prevention

Session: Secondary prevention 2

Thumbnail

Bempedoic acid and PCSK9 inhibitor eligibility in a contemporary population with atherosclerotic cardiovascular disease

Event: ESC Preventive Cardiology 2022

Topic: Secondary Prevention

Session: ePosters

Thumbnail

The demographic, psychosocial and clinical characteristics associated with cardiac risk factor control: an analysis of secondary prevention in adults with established coronary heart disease

Event: ESC Preventive Cardiology 2022

Topic: Secondary Prevention

Session: ePosters

Thumbnail